CLINICAL governance principles designed to support the implementation of safe and high quality pharmacy services were released yesterday by the Pharmaceutical Society of Australia (PSA).
The 26-page document Clinical Governance Principles for Pharmacy Services 2018 guides pharmacists and organisations involved in the provision of pharmacy services on improving safety, quality and consistency of new and existing services in healthcare delivery.
PSA National President, Dr Chris Freeman, said clinical governance was a key mechanism to reduce the harms caused by medicine misuse.
"We have a high-quality health system in Australia, and a high-quality pharmacy profession providing valued care to their communities and patients, but there are still unacceptable variations in health outcomes," he said.
"PSA's Medicine Safety Report found that 250,000 people are admitted to hospital each year because of medicine-related problems, at a cost of $1.4 billion. At least half of this harm is preventable.
"Pharmacists are the key to improving the safe and quality use of medicines but, while all pharmacy services have a degree of quality management and governance, the formal application of clinical governance varies considerably."
See the document psa.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 May 19
